IO Biotech, Inc. (IOBT)

IO Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.03	143.19	142.59	211.53	3.41
Cash & Short-Term Investments	60.03	143.19	142.59	211.53	3.41
Cash Growth	-58.08%	0.42%	-32.59%	6112.36%	-56.60%
Other Receivables	1.13	1.13	1.53	2.09	1.5
Receivables	1.13	1.13	1.53	2.09	1.5
Prepaid Expenses	1.12	1.35	1.72	3.2	-
Other Current Assets	2.67	1.58	2.38	4.92	0.73
Total Current Assets	64.95	147.26	148.22	221.74	5.64
Property, Plant & Equipment	2.36	3.11	3.23	0.16	-
Other Long-Term Assets	0.39	0.36	0.35	0.4	0.02
Total Assets	67.7	150.72	151.81	222.29	5.65
Accounts Payable	4.66	3.88	4	3.93	0.52
Accrued Expenses	13.61	10.62	4.21	5.92	2.27
Current Portion of Leases	0.72	0.66	0.52	-	-
Other Current Liabilities	0.5	0.56	1.95	0.46	0.26
Total Current Liabilities	19.49	15.72	10.68	10.31	3.05
Long-Term Leases	1.2	1.84	2.28	-	-
Other Long-Term Liabilities	-	-	-	0.06	-
Total Liabilities	20.68	17.56	12.95	10.36	3.05
Common Stock	0.07	0.07	0.03	0.03	0.03
Additional Paid-In Capital	413.11	406.59	326.71	319.67	1.11
Retained Earnings	-359.31	-263.82	-177.74	-106.28	-38.4
Comprehensive Income & Other	-6.85	-9.67	-10.14	-1.49	1.96
Total Common Equity	47.02	133.16	138.85	211.92	-35.3
Shareholders' Equity	47.02	133.16	138.85	211.92	2.6
Total Liabilities & Equity	67.7	150.72	151.81	222.29	5.65
Total Debt	1.92	2.49	2.79	-	-
Net Cash (Debt)	58.12	140.7	139.8	211.53	3.41
Net Cash Growth	-58.70%	0.64%	-33.91%	6112.36%	-
Net Cash Per Share	0.88	3.23	4.85	48.79	19.22
Filing Date Shares Outstanding	65.88	65.88	28.82	28.82	0.18
Total Common Shares Outstanding	65.88	65.88	28.82	28.82	0.18
Working Capital	45.47	131.54	137.54	211.43	2.59
Book Value Per Share	0.71	2.02	4.82	7.35	-199.23
Tangible Book Value	47.02	133.16	138.85	211.92	-35.3
Tangible Book Value Per Share	0.71	2.02	4.82	7.35	-199.23
Machinery	1.22	1.18	0.86	0.17	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q